Furthermore, we advocate further investigations that focus on liver‐specific targeting of AATF or the generation of liver‐specific AATF knockout mice, as these approaches will facilitate a comprehensive understanding of the impact of AATF throughout different stages of MASLD. The gene discussed is AATF; the disease is metabolic dysfunction-associated steatotic liver disease.